http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013021128-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ec86abf0422968d0c712bf1aef1ae3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9099f15c29b797b789604ecdeff0cee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e70f8766016e8f9d9aa6ed477f078852 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8ec54fa824beed23854d4cae8e48f58 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-10 |
| filingDate | 2012-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8cc140ed46a81f7ec77d572b783a311 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a45a5012be97407537ad4eea94e1c9c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f573700ec88fa9bc16f43ea9e1b90766 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c24bf198eca44ba1ec20851b419aa65 |
| publicationDate | 2013-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013021128-A3 |
| titleOfInvention | Use of cannabinoid compounds for stimulating melanogenesis |
| abstract | The invention relates to the non-therapeutic, cosmetic use, as an agent for coloring keratin materials, of at least one cannabinoid compound selected from among the compounds of general formula (I), as well as the geometric and optical isomers thereof, the cosmetically acceptable acid or base salts thereof, and the hydrates thereof, i.e. the compounds of formula (I) where: R1 is a hydrogen atom or a C 1 -C 30 alkyl group, said alkyl group being optionally substituted with a hydroxyl group (OH); R 2 is a halogen atom, or a group selected from among hydroxyl, thiol (SH), and amino, optionally substituted with one or more C 1 -C 6 alkyl groups; R 3 and R 4 form an oxo group together with the carbon atom having same, or R 3 and R 4 are a hydrogen atom; R 5 is a hydrogen atom or a C 1 -C 6 alkyl group; X is a heteroatom selected from among the oxygen and sulphur atoms and the divalent group -N(R 6 )-, where R 6 is a hydrogen atom or a C 1 -C 6 alkyl group; - - - - is a single or double bond; n is 1, 2 or 3, preferably 1 or 2, it being understood that when R 3 and R 4 form an oxo group together with the carbon atom having same, and X is an oxygen atom, then R 1 cannot be a hydroxymethyl group. The invention also relates to one of said specific cannabinoid compounds, to be used in the treatment of vitiligo or pityriasis versicolor, to non-therapeutic, cosmetic methods for coloring the skin or for treating the whitening of the hair, which includes topically applying, to the skin and/or to the hair, or orally delivering a composition including, in a physiologically acceptable medium, one of said cannabinoid compounds, and to a method for selecting an active agent that promotes the pigmentation of the keratin materials. |
| priorityDate | 2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.